3 September 2026 Dermatology Dermatomyositis Rheumatology FDA approves first oral dermatomyositis drug
2 April 2026 Clinical research Dermatomyositis Brepocitinib shows promise in phase 3 dermatomyositis trial
30 October 2025 ACR Clinical research Dermatomyositis Neutrophils take centre stage in juvenile dermatomyositis